Oxford PharmaGenesis™ will be showcasing its new HealthScience approach to demonstrating product value and achieving market access at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).
Meet Oxford PharmaGenesis, the HealthScience Communicators, at ISPOR in Montreal, 31 May–3 June
30 May 2014
Oxford PharmaGenesis Value Demonstration Practice is proud to be an exhibitor once again at this year’s ISPOR International Meeting in Montreal, Canada.
Oxford PharmaGenesis launches new HealthScience approach to medical choices
29 May 2014
Leading independent consultancy Oxford PharmaGenesis is pioneering the innovative discipline of HealthScience. For the first time, this integrates the clinical and scientific dimensions of healthcare with the economic, social, behavioural and political perspectives that determine the value of new medicines and health interventions.
Heart failure: a call to raise awareness and save lives
16 May 2014
Addressing heart failure must be considered a global health priority because poor awareness of the disease leads to many premature deaths. Approximately 26 million people are living with heart failure worldwide, and if current trends continue the disease will impose ever-increasing burdens on patients, caregivers and healthcare systems.
Oxford PharmaGenesis welcomes investment in biosciences in Oxfordshire
5 February 2014
Latest tweets
Loading tweets...